Compare StocksAVGO vs EW

Broadcom Inc. (AVGO) vs Edwards Lifesciences Corporation (EW): Which Is the Better Buy in 2026?

As of 2026-06-19, AVGO is overvalued at $411, with a DCF intrinsic value of $258 and a margin of safety of -59%. EW is overvalued at $87, with an intrinsic value of $56 and a margin of safety of -55%. Of the two, EW has the wider margin of safety.

AVGO
Broadcom Inc.
$411.35
VS
EW
Edwards Lifesciences Corporation
$87.36

Rewards

AVGO
  • Gross margin of 76.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 18.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $11.66 of earning power — management is an exceptional capital allocator.
EW
  • Edwards Lifesciences Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 77.9% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Edwards Lifesciences Corporation scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

Risks

AVGO
  • ROIC has declined by 6.5 percentage points over the past 4 years, which may signal competitive erosion.
  • Share count has increased by 13% over the past 4 years, diluting existing shareholders.
  • FCF yield of 1.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
EW
  • FCF yield of 2.7% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 47.2x is 57% above the historical average of 30.1x — the stock trades at a premium to its own history.
  • PEG ratio of 2.13 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
AVGO
EW
Valuation
$27.21B
Free Cash Flow
$1.33B
1.39%
FCF Yield
2.65%
68.22
Trailing P/E
47.22
21.26
Forward P/E
25.94
Quality & Moat
19.14%
ROIC
14.09%
37.28%
ROE
10.46%
76.28%
Gross Margin
77.87%
0.68
PEG Ratio
2.13
Balance Sheet Safety
0.52
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
1.08
Net Debt / EBITDA
-1.56
0.69%
Dividend Yield
0.00%
AVGO: 6Ties: 2EW: 4
AVGOEW

Historical Fundamentals

Learn more →
AVGO

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

EW

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
AVGO
$97.03
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$14.50B
Δ Market Cap
+$1.41T
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
EW
$0.62
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$6.65B
Δ Market Cap
+$4.12B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
AVGO
16.0% Margin of Safety
Price is 16.0% below estimated fair value
Current Price: $411.35
Fair Value: $489.83
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
EW
54.8% Overvalued
Price is 54.8% above estimated fair value
Current Price: $87.36
Fair Value: $56.45
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
AVGO

What growth rate is the market pricing in at $411?

+23.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +25.6%

The market implies +23.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +25.6%, reflecting heavy growth investment.

EW

What growth rate is the market pricing in at $87?

+18.5%
Market-Implied Owner Earnings Growth
Standard FCF implies +15.5%

The market implies +18.5% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +15.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
AVGO
61/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
EW
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
AVGO
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
EW
-2.57
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
AVGO
Insiders 1.9%Institutions 79.9%Retail & Other 18.1%
No. of Institutional Holders6,094
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
EW
Insiders 0.2%Institutions 94.1%Retail & Other 5.7%
No. of Institutional Holders1,866
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
AVGO
0
Buys (3M)
2
Buys (12M)
Total value (12M): $1.55M
YOU HARRY L
Director
$325,129
@ $325.13 · 2025-12-18
YOU HARRY L
Director
$1.23M
@ $345.88 · 2025-09-10
Open market purchases · includes direct & indirect ownership · excludes option exercises
EW
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
AVGO
4
Sells (3M)
29
Sells (12M)
Total value (12M): $241.47M
VELAGA S. RAM
Officer
$2.96M
@ $370.52 · 2026-04-10
VELAGA S. RAM
Officer
$10.64M
@ $352.08 · 2026-04-09
DELLY GAYLA J
Director
$358,310
@ $358.31 · 2026-04-09
PAGE JUSTINE F.
Director
$712,354
@ $353.00 · 2026-04-08
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$19.45M
@ $323.38 · 2026-03-17
VELAGA S. RAM
Officer
$20.82M
@ $323.38 · 2026-03-17
BRAZEAL MARK DAVID
Officer
$27.06M
@ $323.39 · 2026-03-17
KAWWAS CHARLIE B
Officer
$20.97M
@ $323.39 · 2026-03-17
BRAZEAL MARK DAVID
Officer
$10.41M
@ $347.12 · 2026-01-06
TAN HOCK E
Chief Executive Officer
$24.31M
@ $347.30 · 2026-01-06
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$10.43M
@ $347.82 · 2025-12-31
BRAZEAL MARK DAVID
Officer
$9.13M
@ $352.07 · 2025-12-26
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$2.03M
@ $332.91 · 2025-12-17
BRAZEAL MARK DAVID
Officer
$12.54M
@ $327.65 · 2025-12-17
KAWWAS CHARLIE B
Officer
$1.05M
@ $332.95 · 2025-12-17
BRAZEAL MARK DAVID
Officer
$8.36M
@ $340.91 · 2025-12-16
PAGE JUSTINE F.
Director
$289,512
@ $361.89 · 2025-12-15
PAGE JUSTINE F.
Director
$264,912
@ $331.14 · 2025-11-14
PAGE JUSTINE F.
Director
$280,120
@ $350.15 · 2025-10-14
BRAZEAL MARK DAVID
Officer
$9.59M
@ $352.61 · 2025-09-17
KAWWAS CHARLIE B
Officer
$2.26M
@ $352.74 · 2025-09-17
PAGE JUSTINE F.
Director
$288,000
@ $360.00 · 2025-09-15
PAGE JUSTINE F.
Director
$245,968
@ $307.46 · 2025-08-14
PAGE JUSTINE F.
Director
$219,440
@ $274.30 · 2025-07-14
TAN HOCK E
Chief Executive Officer
$10.73M
@ $268.29 · 2025-06-26
DELLY GAYLA J
Director
$795,390
@ $265.13 · 2025-06-26
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$9.50M
@ $261.27 · 2025-06-24
BRAZEAL MARK DAVID
Officer
$13.11M
@ $262.10 · 2025-06-24
BRAZEAL MARK DAVID
Officer
$12.66M
@ $253.28 · 2025-06-23
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$14.18M
@ $251.75 · 2025-06-18
PAGE JUSTINE F.
Director
$200,280
@ $250.35 · 2025-06-16
PAGE JUSTINE F.
Director
$184,152
@ $230.19 · 2025-05-14
PAGE JUSTINE F.
Director
$148,000
@ $185.00 · 2025-04-14
BRAZEAL MARK DAVID
Officer
$5.84M
@ $194.65 · 2025-03-24
LOW CHECK KIAN
Director
$11.30M
@ $235.35 · 2025-01-06
BRAZEAL MARK DAVID
Officer
$4.82M
@ $238.79 · 2024-12-24
TAN HOCK E
Chief Executive Officer
$10.80M
@ $239.96 · 2024-12-24
BRYANT DIANE M
Director
$3.40M
@ $226.68 · 2024-12-23
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$2.89M
@ $229.62 · 2024-12-20
YOU HARRY L
Director
$1.57M
@ $240.00 · 2024-12-17
BRAZEAL MARK DAVID
Officer
$3.43M
@ $181.45 · 2024-10-11
BRAZEAL MARK DAVID
Officer
$3.46M
@ $182.88 · 2024-10-09
BRAZEAL MARK DAVID
Officer
$3.59M
@ $177.10 · 2024-10-07
DELLY GAYLA J
Director
$130,898
@ $174.53 · 2024-09-25
PAGE JUSTINE F.
Director
$444,566
@ $1750.26 · 2024-06-20
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
EW
8
Sells (3M)
27
Sells (12M)
Total value (12M): $15.81M
DAHL ANDREW M
Officer
$48,853
@ $86.16 · 2026-05-29
CHOPRA DAVEEN
Officer
$126,905
@ $84.60 · 2026-05-22
LIPPIS DANIEL J
Officer
$50,307
@ $81.14 · 2026-05-18
MARKOWITZ WAYNE
Officer
$47,280
@ $79.73 · 2026-05-11
LIPPIS DANIEL J
Officer
$170,160
@ $83.49 · 2026-05-04
ULLEM SCOTT B
Chief Financial Officer
$1.04M
@ $80.04 · 2026-04-09
LIPPIS DANIEL J
Officer
$82,523
@ $80.98 · 2026-04-06
BOBO DONALD E JR
Officer
$1.82M
@ $80.16 · 2026-04-02
LIPPIS DANIEL J
Officer
$87,004
@ $85.38 · 2026-03-11
ULLEM SCOTT B
Chief Financial Officer
$1.10M
@ $84.92 · 2026-03-11
BOBO DONALD E JR
Officer
$974,430
@ $85.93 · 2026-03-02
BOBO DONALD E JR
Officer
$2.01M
@ $83.84 · 2026-02-25
ZOVIGHIAN BERNARD J
Chief Executive Officer
$1.72M
@ $76.67 · 2026-02-12
LIPPIS DANIEL J
Officer
$87,332
@ $85.70 · 2026-01-09
BOBO DONALD E JR
Officer
$971,429
@ $85.66 · 2026-01-06
STONE HEISZ LESLIE
Director
$218,120
@ $83.41 · 2025-12-12
BOBO DONALD E JR
Officer
$953,748
@ $83.76 · 2025-12-12
LIPPIS DANIEL J
Officer
$85,625
@ $84.03 · 2025-12-12
CHOPRA DAVEEN
Officer
$168,750
@ $84.38 · 2025-12-11
BOBO DONALD E JR
Officer
$950,581
@ $83.83 · 2025-12-10
ULLEM SCOTT B
Chief Financial Officer
$650,412
@ $84.47 · 2025-12-09
MARKOWITZ WAYNE
Officer
$50,144
@ $86.01 · 2025-12-08
LIPPIS DANIEL J
Officer
$84,196
@ $82.55 · 2025-11-10
ULLEM SCOTT B
Chief Financial Officer
$1.08M
@ $83.08 · 2025-11-10
CHOPRA DAVEEN
Officer
$204,865
@ $81.95 · 2025-08-25
WOOD LARRY L
Officer
$698,679
@ $78.06 · 2025-08-18
LIPPIS DANIEL J
Officer
$326,900
@ $79.46 · 2025-07-28
WOOD LARRY L
Officer
$673,268
@ $75.23 · 2025-06-16
BOBO DONALD E JR
Officer
$198,911
@ $77.40 · 2025-06-02
CHOPRA DAVEEN
Officer
$112,612
@ $75.07 · 2025-05-22
LIPPIS DANIEL J
Officer
$24,560
@ $74.42 · 2025-05-09
ULLEM SCOTT B
Chief Financial Officer
$837,035
@ $74.40 · 2025-05-09
MARKOWITZ WAYNE
Officer
$20,121
@ $75.08 · 2025-05-07
ZOVIGHIAN BERNARD J
Chief Executive Officer
$447,977
@ $74.91 · 2025-05-05
BOBO DONALD E JR
Officer
$663,196
@ $69.81 · 2025-04-14
LIPPIS DANIEL J
Officer
$21,183
@ $70.61 · 2025-04-08
ULLEM SCOTT B
Chief Financial Officer
$797,267
@ $70.87 · 2025-03-26
BOBO DONALD E JR
Officer
$645,624
@ $67.96 · 2025-03-13
LIPPIS DANIEL J
Officer
$27,792
@ $69.48 · 2025-03-10
ZOVIGHIAN BERNARD J
Chief Executive Officer
$428,448
@ $69.51 · 2025-03-10
ULLEM SCOTT B
Chief Financial Officer
$796,327
@ $70.78 · 2025-02-28
LORANGER STEVEN R
Director
$438,576
@ $76.42 · 2025-02-14
STONE HEISZ LESLIE
Director
$435,371
@ $75.86 · 2025-02-13
BOBO DONALD E JR
Officer
$492,363
@ $75.75 · 2025-02-13
LIPPIS DANIEL J
Officer
$38,170
@ $76.34 · 2025-02-13
ULLEM SCOTT B
Chief Financial Officer
$852,272
@ $75.76 · 2025-02-13
BOBO DONALD E JR
Officer
$343,736
@ $68.75 · 2025-01-16
LIPPIS DANIEL J
Officer
$34,382
@ $68.76 · 2025-01-16
LIPPIS DANIEL J
Officer
$185,196
@ $74.08 · 2024-12-16
BOBO DONALD E JR
Officer
$358,750
@ $71.75 · 2024-12-09
ULLEM SCOTT B
Chief Financial Officer
$806,406
@ $71.68 · 2024-12-09
CHOPRA DAVEEN
Officer
$128,223
@ $73.27 · 2024-12-06
MARKOWITZ WAYNE
Officer
$42,716
@ $73.27 · 2024-12-06
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
AVGO
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
EW
FearGreed
😏Greed(64/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
AVGO
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
EW
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (64)
View AVGO Full AnalysisView EW Full Analysis

Frequently Asked Questions: AVGO vs EW

Is Broadcom Inc. or Edwards Lifesciences Corporation more undervalued in 2026?

Based on our discounted cash flow model, EW trades at a -54.8% margin of safety (intrinsic value $56 vs. price $87), compared to AVGO's -59.4% margin of safety (intrinsic $258 vs. $411).

Which stock has a wider economic moat, Broadcom Inc. or Edwards Lifesciences Corporation?

EW scores 80/100 (Wide moat), while AVGO scores 61/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Which company has better free cash flow, Broadcom Inc. or Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation (EW) generates a 2.7% free cash flow yield, compared to Broadcom Inc.'s 1.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Broadcom Inc. or Edwards Lifesciences Corporation?

AVGO earns 19.1% ROIC versus EW's 14.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.